The healthcare community is excited by retatrutide, a innovative dual GIP and GLP-1 receptor that’s showing impressive results in preliminary research. This compound works by imitating natural hormones to impact appetite and promote feelings of satisfaction , ultimately contributing to substantial weight reduction . While presently under evaluati